IPCALAB2021-01-012021-03-31in-bse-fin:OneOperatingExpenses01Member IPCALAB2021-01-012021-03-31in-bse-fin:FourOperatingExpenses01Member IPCALAB2021-01-012021-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member IPCALAB2021-01-012021-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member IPCALAB2021-01-012021-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member IPCALAB2021-01-012021-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member IPCALAB2021-01-012021-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member IPCALAB2021-01-012021-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member IPCALAB2021-01-012021-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member IPCALAB2021-01-012021-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares IPCALAB 2020-04-01 2021-03-31 2021-05-17 INR Crores Yearly true Cash Flow Indirect Single segment Pharmaceuticals 2021-01-01 2021-03-31 Audited Consolidated 11146600000.00 199200000.00 11345800000.00 4175600000.00 1024400000.00 -1814100000.00 2576300000.00 17000000.00 525000000.00 2895300000.00 9399500000.00 1946300000.00 0.00 1946300000.00 357200000.00 -47900000.00 309300000.00 0.00 1637000000.00 0.00 0.00 0.00 -25000000.00 1612000000.00 12300000.00 1624300000.00 1613400000.00 -1400000.00 1625900000.00 -1600000.00 253700000.00 2 12.71 12.71 0.00 0.00 12.71 12.71 1 The above audited consolidated financial statements relates to Ipca Laboratories Ltd. and its Subsidiary Companies, Associates and Joint Venture. The consolidated financial statements have been prepared in accordance with Companies (Indian Accounting Standards) Rules, 2015. 2 The above audited consolidated financial results, as reviewed by the Audit Committee, were approved and taken on record by the Board of Directors in their meeting held on May 28, 2021. 3 In accordance with Ind AS-108 Operating Segments , the operations of the Group are categorised in one segment viz Pharmaceuticals. The geographic information of the Group's revenues by the Company's country of domicile and other countries is tabulated hereunder: (Rs. Crores) Particulars 2020-21 2019-20 Segment Revenue - India 2456.93 2216.2 - Outside India 2963.06 2432.4 Total 5419.99 4648.71 The geographic information of the Non-current assets outside India is less than 10% of the total Non-current assets of the Group and therefore, not disclosed separately. 4 *The figures of the last quarter for the current year and for the previous year are the balancing figures between the audited figures in respect of the full financial year ended March 31, and unaudited year-to-date figures up to the third quarter ended December 31, which were subjected to limited review. 5 Figures for the previous period have been regrouped / re-classified to conform to the figures of the current period. Single segment 2020-04-01 2021-03-31 Audited Consolidated 54199900000.00 628400000.00 54828300000.00 15971400000.00 3259500000.00 -1947900000.00 10135700000.00 90400000.00 2091700000.00 11337700000.00 40938500000.00 13889800000.00 0.00 13889800000.00 2486400000.00 -85000000.00 2401400000.00 0.00 11488400000.00 0.00 0.00 0.00 -77000000.00 11411400000.00 -4000000.00 11407400000.00 11400100000.00 11300000.00 11398400000.00 9000000.00 253700000.00 2 46762800000.00 90.11 90.11 0.00 0.00 90.11 90.11 Other expenses 2895300000.00 Other expenses 11337700000.00 90400000.00 -2716900000.00 967500000.00 0.00 -66100000.00 7700000.00 -5400000.00 -175400000.00 0.00 559500000.00 0.00 -967000000.00 -1100000.00 2091700000.00 0.00 93000000.00 63300000.00 -122400000.00 0.00 -171300000.00 0.00 369500000.00 0.00 5300000.00 0.00 28600000.00 0.00 155500000.00 0.00 -532600000.00 13357200000.00 0.00 0.00 0.00 2455900000.00 0.00 10901300000.00 0.00 0.00 0.00 477200000.00 0.00 0.00 0.00 0.00 25700000.00 3615500000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 340000000.00 6000000.00 0.00 0.00 0.00 217800000.00 0.00 -1023700000.00 0.00 -5206900000.00 0.00 0.00 358100000.00 0.00 0.00 0.00 0.00 0.00 28300000.00 2286200000.00 14900000.00 59000000.00 1015300000.00 69200000.00 0.00 0.00 -3058200000.00 2636200000.00 0.00 2636200000.00 2953900000.00 5590100000.00